Drugs that interrupt the RAS like angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptors blockers (ARBs) are likely to be beneficial in the prevention of diabetes [10,12]. This evidence concerns the gene ACE and diabetes mellitus.